Tag: CKD
Revelation Biosciences announces US FDA acceptance of Gemini IND
Revelation Biosciences recently announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application for Gemini. The company referred...
Roivios unveils promising new clinical data on the JuxtaFlow Renal Assist...
Roivios has announced today via press release new clinical data from the BIPASS-AKI Feasibility Study of the JuxtaFlow Renal Assist Device (RAD). Presented at...
Global, national, and regional trends in the burden of chronic kidney...
A recent analysis reveals that the number of chronic kidney disease (CKD) cases in women around the globe nearly tripled in the past three...
Akebia Therapeutics and U.S. Renal Care sign commercial supply contract to...
Akebia Therapeutics and U.S. Renal Care (USRC) have recently announced entry into a multi-year commercial supply contract encompassing all USRC dialysis centres. The contract...
Pooled analysis of over 18,000 participants supports benefits of finerenone across...
A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events...
JSN and ERA announce joint symposium on kidney health in ageing...
The Japanese Society of Nephrology (JSN) and the European Renal Association (ERA) have recently announced a joint symposium on Kidney Health in Ageing and...
The NKF launches new online educational tool for people living with...
The National Kidney Foundation (NKF) has today launched NKF Patient Journey: Chronic Kidney Disease, a new interactive, online learning tool that it hopes will aid people living...
Endothelial tight junctions and their role in vascular access
Nikos Giannikas and Panos Kitrou (Patras, Greece) write together about the role that endothelial tight junctions play in vascular access, evidence from previous studies,...
Semaglutide reduces risk for major kidney disease events in patients with...
Findings from the FLOW trial, the first dedicated kidney outcomes trial with a glucagon-like peptide-1 (GLP-1) receptor agonist were reported at a symposium at...
ATTEMPT study shows that SGLT2 inhibitors can improve kidney function in...
Findings from the ATTEMPT (The adolescent type 1 diabetes treatment with SGLT2i for hyperglycaemia and hyperfiltration trial) study that show that a low dose...
Renal Interventions’ top 10 stories of May 2024
In May, we saw revolutionary new devices, trials that show promise for the future of chronic kidney disease (CKD), and the role of medication...
International support a focal point of VASA 2024 Henry Lecture
Prior to the recent Vascular Access Society of the Americas (VASA) Vascular Access for Hemodialysis Symposium (16–18 May, Atlanta, USA), Renal Interventions spoke to...
UKKA hyperkalaemia guidelines update focuses on optimal treatments in the right...
Following the publication of the updated UK Kidney Association (UKKA) clinical practice guidelines on the treatment of acute hyperkalaemia in adults in 2023, Renal...
Semaglutide significantly reduces risk of major kidney disease events and mortality...
A study recently published in the New England Journal of Medicine (NEJM) has demonstrated that semaglutide (Novo Nordisk) significantly reduces the risk of major...
UKKA RaDaR study provides new insight into the effects of rare...
In a recent paper published in March 2024 in The Lancet, Katie Wong (Department of Renal Medicine, University College London, London, UK) et al...
Significant milestones of the Alio SmartPatch™ to enable remote monitoring of...
This advertorial is sponsored by Alio
With one in three people living with diabetes and one in five with hypertension, the risk of chronic kidney...
FLOW trial shows reduction in kidney disease progression in patients with...
Novo Nordisk has announced via press release the headline results from the kidney outcomes trial FLOW, coming after the decision to stop the trial...
MultiOmic Health and Queen’s University Belfast collaborate for future of diabetic...
MultiOmic Health has partnered with the Centre for Public Health at Queen’s University Belfast (QUB) on a collaborative project to develop data-driven diagnostic tools...
First subjects enrolled in US clinical trial for VenoStent
VenoStent has announced that the first subjects have been enrolled in the SAVE-FistulaS clinical trial, which will take place at two different sites across...
The FLEX vessel prep system: working to extend time and improve...
This advertorial is sponsored by VentureMed Group.
Arteriovenous (AV) access is challenging and dialysis is hard on the body and the mind. It causes physical...
New option for chronic kidney failure patients emerges as Ozempic trial...
Ozempic (Novo Nordisk) is a once-daily injection with US Food and Drug Administration (FDA) approval for use as a preventative treatment for strokes and...
Chronic kidney disease is biggest risk factor for mortality after stroke...
A new retrospective cohort observational study published in the journal Medicine by Maria Mirabela Manea (Carol Davila University of Medicine and Pharmacy, Bucharest, Romania)...
Renal Interventions’ top 10 stories of November 2023
November was a month of demands for more vascular access (VA) training, novel technologies, and regulations, with Terry Litchfield highlighting the importance of compliance...
Shares drop for dialysis providers as Ozempic kidney failure study’s early...
In early October, Novo Nordisk announced they will stop the kidney outcomes trial FLOW at interim, after initial results and the recommendation from the...
Study shows Klinrisk model able to predict of chronic kidney disease...
A new validation study regarding the Klinrisk model—a machine-learning tool developed to predict the risk of chronic kidney disease (CKD) progression—has been conducted by...
Only 40% of diabetes patients get recommended kidney health testing, say...
Not enough diabetes patients are getting their recommended kidney health screenings, according to a new study by the US National Kidney Foundation (NKF) and...
CKD patient outcomes affected by low screening rates in deprived areas,...
Vizient has announced the publication of its first public report on care utilisation and quality in the USA using data from Medicare's Data Sharing for...
Renal Interventions 9 – US
Highlights
Patient perspectives highlighted in conversation with representatives Vivian Papageorgiou and Phil West.
Endo Vascular Access Meeting 2023 (EVA; 23–24 June, Patras, Greece) coverage...
Renal Interventions 9 – EU
Highlights
Patient perspectives highlighted in conversation with representatives Vivian Papageorgiou and Phil West.
Endo Vascular Access Meeting 2023 (EVA; 23–24 June, Patras, Greece) coverage...
“Take time to connect”: Patient perspectives and mental impact in the...
A renal disease diagnosis is “a shock at any age”, and its “huge impact” on the lives of patients and their families is something...
Blood test may predict heart, kidney risk for those with type...
A simple blood test may predict the risk of progressive kidney and heart disease in people with type 2 diabetes and kidney disease, according to new...
Digital counselling programme promises quality of life improvements for CKD patients
A new study published in Kidney360 has examined the efficacy potential of a new programme aimed at providing “automated, scalable, digital counselling” to chronic...
Mitochondrial transplantation found effective in reversing kidney damage
A new preclinical study, led by scientists at Wake Forest University School of Medicine (Winston-Salem, USA), shows that a new technology called mitochondrial transplantation holds...
ASPEN trial finds roxadustat effective for treating anaemia in large dialysis...
New research has been published in Hemodialysis International which, say its authors, “enhances understanding” of how haemodialysis centres can utilise oral roxadustat. The anaemia...
Acute kidney injury not associated with worsening of CKD in new...
Acute kidney injury (AKI) is considered by many to cause accelerated loss of kidney function—but, according to the authors of new research published in...
Empagliflozin recommended for CKD by European Medicines Agency body
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance (empagliflozin) for...
Age-based nephrosclerosis threshold better predicts CKD progression
Researchers including lead Muhammad Asghar and corresponding author Andrew D Rule (both Mayo Clinic, Rochester, USA) have published the results of a study comparing...
Renalytix granted FDA De Novo authorisation for CKD test
Renalytix has announced that the US Food and Drug Administration (FDA) has granted De Novo marketing authorisation for its KidneyIntelX.dkd prognostic test for chronic...
Even modest kidney function reduction increases health risks in young adults
A study of more than 8 million adults in Ontario, Canada has suggested that even a modest loss of kidney function is associated with...
Renalytix announces publication of real-world evidence on KidneyIntelX risk assessment test
Renalytix has announced the release of new real-world evidence case studies published in the peer reviewed journal Diabetic Nephropathy entitled: “The Need for Risk...
Smartphone CKD test wins digital health innovation award
Juniper Research's Future Digital Awards 2023 has announced Healthy.io as the platinum winner for 'Best Digital Diagnostics Solution' in the Digital Health Innovation category...
Proteomic tool promises prediction of cardiovascular risk in CKD patients
A new proteomic risk model for cardiovascular disease in chronic kidney disease (CKD) patients has been found to be more accurate than current methods...
Biomarkers in urine and blood predict AKI progression to CKD, study...
In a new study looking at the long-term effects of hospitalised patients who have acute kidney injury (AKI), Johns Hopkins Medicine (Baltimore, USA) researchers...
New-onset CKD found less likely with partial rather than radical nephrectomy
A study in Urologic Oncology led by Mario Ochoa-Arvizo (University of Edinburgh, Edinburgh, UK) has found that partial nephrectomy is less likely to result...
SAVS 2023: Study points toward CKD patients who would most benefit...
A new study probing which chronic kidney disease (CKD) patients would benefit most from renal artery stenting points toward those who experience a more...
Fruit and vegetable intake cuts CKD risk, study suggests
A new study of Japanese patients with and without chronic kidney disease (CKD) found that a lower frequency of vegetable and fruit intake was...
Alio wins 2023 IoT Breakthrough Winner award, announces new CMO
Alio, a medical technology company reinventing the management of chronic disease, has announced that it has been selected as winner of the “IoT Health...
Study: Older patients’ knowledge improved by multidisciplinary care
Chronic kidney disease (CKD) patients who are older or more vulnerable can achieve similar outcomes with their treatment, particularly on understanding of it and their...
Risk equation incorporates lifestyle data to predict CKD
Integrating patient-reported data on lifestyle and health information could help clinicians predict incident chronic kidney disease (CKD)—that’s the position of the authors behind a...
Fishing for supplements: Seafood-based omega 3 cuts CKD
Increased levels of omega 3 polyunsaturated fatty acids (n-3 PUFAs) can cut the risk of incident chronic kidney disease (CKD) and lead to a...
KDIGO guideline for diabetic CKD patient treatment updated
The Kidney Disease: Improving Global Outcomes (KDIGO) Work Group has issued a 2022 update to its 2020 guideline for the management of diabetes in...
Urinary peptidome analysis “a useful tool” for CKD prediction
A study recently published in Kidney International Reports (KIR) has found that urinary peptidome (UP) analysis can help predict a patient’s risk of developing...
XORTX submits patent application for methods for early detection of kidney...
XORTX Therapeutics, a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the submission of...
DART decision aid improves decision quality for CKD patients over 70,...
A web-based decision aid can improve the quality of treatment decisions made by patients over 70 with chronic kidney disease (CKD)—that is the conclusion...
NHS Scotland treatment of CKD with finerenone accepted by SMC
Bayer has announced that Kerendia (finerenone, 10mg and 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) antagonist, has been accepted for use within...
ASN Kidney Week: First-time data on transplant surgeries, cooler dialysate and...
Late-breaking data from multiple high-impact clinical trials were presented at the recent 2022 American Society of Nephrology (ASN) Kidney Week (3–6 November, Orlando, USA)—with...
National Kidney Foundation launches new kidney disease public education series
The National Kidney Foundation (NKF) has launched a new animated video series aimed at educating people on their chronic kidney disease (CKD) risk. ‘Kidney Numbers and the CKD...
SGLT2 inhibitors demonstrate efficacy and safety in diabetic kidney transplant recipients
Sodium-glucose cotransporter-2 (SGLT2) inhibitors can be used safely to help preserve graft function in diabetic kidney transplant recipients, as per the findings from a...
New research sheds light on impact of recent eGFR updates
New research indicates that removing a race modifier from a formula used to diagnose kidney disease—estimated glomerular filtration rate (eGFR)—could lead to more equitable...
Late-breaking clinical trials reinforce importance of early detection and treatment in...
Three late-breaking clinical trials presented at the 59th European Renal Association (ERA) congress (19–22 May, Paris, France) have placed increased focus on the need...
The Alio SmartPatch™: Optimising dialysis patient monitoring with a wearable, non-invasive...
This advertorial is sponsored by Alio Medical
Owing to the various risk factors and potential complications faced by kidney disease patients undergoing dialysis treatment, new...
Fresenius launches My Reason campaign to enrol patients in kidney-focused genomics...
Fresenius Medical Care announced today that its Global Medical Office has launched the My Reason campaign to promote patient enrolment in the company's kidney-focused genomics registry, which was...
Charmaine Lok
Equally at home on the ward seeing patients, at study sites conducting research, and travelling the world for voluntary medical missions, Charmaine Lok has...
Fresenius announces NCQA accreditation for KidneyCare:365 programme
Fresenius Medical Care North America (FMCNA) has announced that its KidneyCare:365 chronic kidney disease (CKD) health programme has been awarded Population Health Program (PHP) accreditation...
Video-based telemedicine used to facilitate care across all kidney disease stages
Video-based telemedicine is used to facilitate care across all stages of chronic kidney disease (CKD) and has evolved in recent years to be less...
University of Maryland Medicine to eliminate race from kidney function estimates
University of Maryland Medicine—which is comprised of the University of Maryland Medical System (UMMS) and the University of Maryland School of Medicine (UMSOM)—has announced...
Baxter launches My Kidney Journey portal to support kidney disease patients...
Baxter Asia Pacific (Baxter) has announced the launch of My Kidney Journey—a comprehensive online portal intended to support patients living with chronic kidney disease (CKD) in the Asia...
ASN Kidney Week: High-impact clinical trials yield results with capacity to...
The results of several high-impact clinical trials with the potential to impact kidney-related medical care in the future were presented at this year’s American...
Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study
Medtronic today announced findings from a new study of patient preferences for the treatment of hypertension. The findings are set to be presented during...
CMS takes “decisive steps” to reduce healthcare disparities among kidney disease...
The Centers for Medicare & Medicaid Services (CMS) is taking action to close health equity gaps by providing Medicare patients living with end-stage renal...
Strive Health unveils dedicated platform to help nephrologists deliver holistic, patient-centred...
Strive Health has announced Strive Care Partners (SCP)—a dedicated platform that enables nephrologists to share and succeed in global risk contracts with payors, according...
Diaverum launches 2021 travel guide for dialysis patients
Diaverum, a global renal care service provider, has launched its first ever holiday dialysis travel guide in an effort to “empower renal patients worldwide...
Monogram Health raises US$160 million in funding to accelerate “next-generation” kidney...
Monogram Health, a benefit management and care delivery company attempting to transform care for individuals with chronic kidney disease (CKD) and end-stage renal disease...
ERA-EDTA announces name change following late-breaking clinical data at 2021 congress
Fresh evidence on the usefulness of sonography to ease the burden of lung congestion in haemodialysis patients and “promising data” on a long-awaited targeted...